These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29522576)

  • 21. Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods.
    Riederer K; Shemes S; Chase P; Musta A; Mar A; Khatib R
    J Clin Microbiol; 2011 Jun; 49(6):2147-50. PubMed ID: 21490190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of heteroresistant vancomycin intermediate Staphylococcus aureus among MRSA isolates.
    Gazel D; Erinmez M; Büyüktaş Manay A; Zer Y
    J Infect Dev Ctries; 2021 Jan; 15(1):89-94. PubMed ID: 33571150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid Discrimination between Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus Using MALDI-TOF Mass Spectrometry.
    Sogawa K; Watanabe M; Ishige T; Segawa S; Miyabe A; Murata S; Saito T; Sanda A; Furuhata K; Nomura F
    Biocontrol Sci; 2017; 22(3):163-169. PubMed ID: 28954959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?
    Claeys KC; Lagnf AM; Hallesy JA; Compton MT; Gravelin AL; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1708-16. PubMed ID: 26729497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Biomarker Discovery for Methicillin-Sensitive, Heterogeneous Vancomycin-Intermediate and Vancomycin-Intermediate
    Liu YC; Lu JJ; Lin LC; Lin HC; Chen CJ
    J Proteome Res; 2021 Jan; 20(1):164-171. PubMed ID: 33058664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid identification and discrimination of methicillin-resistant Staphylococcus aureus strains via matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu X; Su T; Hsu YS; Yu H; Yang HS; Jiang L; Zhao Z
    Rapid Commun Mass Spectrom; 2021 Jan; 35(2):e8972. PubMed ID: 33053243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and PCR-based rapid diagnosis of Staphylococcus aureus bacteraemia.
    Clerc O; Prod'hom G; Senn L; Jaton K; Zanetti G; Calandra T; Greub G
    Clin Microbiol Infect; 2014 Apr; 20(4):355-60. PubMed ID: 23991748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus.
    Katayama Y; Azechi T; Miyazaki M; Takata T; Sekine M; Matsui H; Hanaki H; Yahara K; Sasano H; Asakura K; Takaku T; Ochiai T; Komatsu N; Chambers HF
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
    Tran N; Rybak MJ
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS; Jones RN; Rossi KL; Rybak MJ
    J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
    Gomes DM; Ward KE; LaPlante KL
    Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rapid method study of methicillin-resistant Staphylococcus aureus identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry].
    Sun Z; Zhang W; Chen X
    Wei Sheng Yan Jiu; 2011 May; 40(3):375-8. PubMed ID: 21695918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Sanprasitthiprasong Hospital.
    Panomket P; Thirat S; Wanram S; Sranujit RP
    J Med Assoc Thai; 2014 Apr; 97 Suppl 4():S7-11. PubMed ID: 24851558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America.
    Castro BE; Rios R; Carvajal LP; Vargas ML; Cala MP; León L; Hanson B; Dinh AQ; Ortega-Recalde O; Seas C; Munita JM; Arias CA; Rincon S; Reyes J; Diaz L
    J Antimicrob Chemother; 2022 Dec; 78(1):122-132. PubMed ID: 36322484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigation of reduced vancomycin susceptibility in methicillin-resistant staphylococci].
    Kuşcu F; Oztürk DB; Gürbüz Y; Tütüncü EE; Sencan I; Gül S
    Mikrobiyol Bul; 2011 Apr; 45(2):248-57. PubMed ID: 21644067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated categorization of methicillin-resistant Staphylococcus aureus clinical isolates into different clonal complexes by MALDI-TOF mass spectrometry.
    Camoez M; Sierra JM; Dominguez MA; Ferrer-Navarro M; Vila J; Roca I
    Clin Microbiol Infect; 2016 Feb; 22(2):161.e1-161.e7. PubMed ID: 26482268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of methicillin-resistant Staphylococcus aureus major clonal lineages by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).
    Zhang T; Ding J; Rao X; Yu J; Chu M; Ren W; Wang L; Xue W
    J Microbiol Methods; 2015 Oct; 117():122-7. PubMed ID: 26253802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
    Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT
    Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN; Rybak MJ
    J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.